NCT03060876

Brief Summary

This register study collects data of patients with proximal humerus and humerus shaft fractures to monitor the healing process by assessing shoulder function and quality of life according to the treatment method (operative or conservative management).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

June 8, 2016

Completed
9 months until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

February 23, 2017

Status Verified

June 1, 2016

Enrollment Period

5 years

First QC Date

June 8, 2016

Last Update Submit

February 21, 2017

Conditions

Keywords

shoulder fractureshumeral fracturesoperative therapyconservative therapyrange of motion, articularquality of lifeproximal

Outcome Measures

Primary Outcomes (4)

  • Constant Shoulder Score (CS) (change over time)

    The CS is a commonly used outcome measure for assessing the outcomes of the treatment of shoulder disorders including the pain score, functional assessment, range of motion and strength measures. In week 6, 52 and in the yearly follow ups for comparison reasons the investigators also assess the CS of the not affected shoulder. Reported value is the impaired shoulder-functionality in percent. 100% are equivalent to an unimpaired shoulder function.

    following a aftercare treatment plan with follow ups after 6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

  • DASH (change over time)

    The Disabilities of the Arm, Shoulder and Hand (DASH) scoring system was developed to assess the level of disability for any patient with any condition affecting the upper limb by covering domains including symptoms, physical function, social function and psychological function.

    following a aftercare treatment plan with follow ups after 1,3,6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

  • Health related quality of life: EuroQoL (EQ-5D-3L+5L) (change over time)

    The EQ-5D-3L/5L is a standardized instrument for use as a measure of health outcome. It was designed for self-completion covering mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Furthermore, health state is indicated by a Visual Analog Scale (VAS). EQ-5D assesses the health status of the patients in an one-dimensional number (1-3/1-5).

    following a aftercare treatment plan with follow ups after 1,3,6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

  • Subjective Shoulder Value (SSV) (change over time)

    The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%.

    following a aftercare treatment plan with follow ups after 1,3,6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

Secondary Outcomes (2)

  • healing process (change over time)

    following a aftercare treatment plan with follow ups after 1, 3, 6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

  • general health conditions

    Baseline week 1

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with proximal humerus fracture

You may qualify if:

  • patients with trauma-related proximal humerus and humerus shaft fracture
  • cognitively able to fill out a questionaire
  • signed informed consent

You may not qualify if:

  • patients with oncological-related proximal humerus and humerus shaft fracture
  • cognitively not able to fill out a questionaire
  • no informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hanover medical school /trauma surgery

Hanover, Lower Saxony, Germany

RECRUITING

Related Publications (1)

  • Razaeian S, Hawi N, Zhang D, Liodakis E, Krettek C. Conservative treatment of displaced isolated proximal humerus greater tuberosity fractures: preliminary results of a prospective, CT-based registry study. Eur J Trauma Emerg Surg. 2022 Dec;48(6):4531-4543. doi: 10.1007/s00068-020-01453-7. Epub 2020 Sep 15.

MeSH Terms

Conditions

Shoulder FracturesHumeral Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesShoulder InjuriesArm Injuries

Study Officials

  • Christian Krettek, Prof. Doc.

    Hanover medical school trauma surgery// trauma foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bianca Kramer, B.Sc.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2016

First Posted

February 23, 2017

Study Start

June 1, 2016

Primary Completion

June 1, 2021

Study Completion

June 1, 2025

Last Updated

February 23, 2017

Record last verified: 2016-06

Locations